Merge pull request #627 from NHSDigital/2026/09/16-AO-NBRS-4983-IG-1.12.1

2026/09/16-AO-NBRS-4983-IG-1.12.1

Author: d-dreyer

guides/Live-ImplementationGuide-BaRS/Home/Applications/BaRS-Applications/Applications/BaRS-APP5/Referral-Payload.page.md

@@ -478,7 +478,7 @@ This payload is used to transmit all the necessary information that is required
 <p>
 <details>
   <summary>> <b class="barslink">MedicationStatement </b></summary>
-  <p> This resource MAY be used to carry new medication prescribed at the encounter. This SHOULD NOT be used to carry Medication History obtained from external sources.</p>
+  <p> This resource is used to carry **new** medication prescribed at the encounter. This SHOULD NOT be used to carry Medication History obtained from external sources.</p>
         {{tree:https://fhir.hl7.org.uk/StructureDefinition/UKCore-MedicationStatement , hybrid}}
         <p>
 
@@ -550,7 +550,7 @@ This payload is used to transmit all the necessary information that is required
 <p>
 <details>
   <summary>> <b class="barslink">Allergy Intolerance</b></summary>
-  <p>This resource MAY be used to carry new Allergies confirmed at the senders encounter. This SHOULD NOT be used to carry Allergy History obtained from external sources.</p>
+  <p>This resource is used to carry **new** Allergies confirmed at the senders encounter. This SHOULD NOT be used to carry Allergy History obtained from external sources.</p>
         {{tree:https://fhir.hl7.org.uk/StructureDefinition/UKCore-AllergyIntolerance , hybrid}}
         <p>
 

guides/Live-ImplementationGuide-BaRS/Home/Applications/BaRS-Applications/Applications/BaRS-APP5/Scope-and-Requirements.page.md

@@ -56,8 +56,8 @@ The payload and workflow have been designed to support this service. Other {{pag
 - The referral Sender **must** include the Pharmacy Service that the request is intended for (from the defined list)
 - The referral Sender **must** indicate consent to share (for Direct Care) to the Receiver 
 - The referral Sender **should** indicate the urgency (providing timeframe within which included actions are expected to take place) of the request to the Receiver 
-- The referral Sender **must** indicate novel medications, established during the latest assessment and not available on existing records, to the Receiver 
-- The referral Sender **must** indicate novel allergies, established during the latest assessment and not available on existing records, to the Receiver 
+- The referral Sender **must** indicate medications administered or prescribed during the latest assessment and not available on existing records to the Receiver. 
+- The referral Sender **must** indicate new allergies, established during the latest assessment and not available on existing records, to the Receiver.
 - The referral Sender **must** indicate localised Special Patient Notes (SPNs) to the Receiver, if they hold any for the patient
 - The referral Sender **must** include the sending organisation type (organization.type in FHIR) to indicate the referral entry method into a Receiver
 - The referral Sender **should** include the Body Mass Index (BMI) of the patient being referred